ERS GenomicsJun28New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurgeby ERS Genomics | June 28, 2022185Dublin, Ireland | ERS Genomics Limited [1] (‘ERS’) is pleased to announce a new license agreement with Cytosurge AG [2] (‘Cytosurge‘). This is a non-exclusive licensing agreement granting Cytosurge ac... Read more > Press ReleaseCorporateFluidFM ApplicationsJun 28, 2022Press Release
Claudia FreyJun27The start-ups taking nanoneedles into the clinicby Claudia Frey | June 27, 202268Nature Nanotechnology | Nanoneedle start-ups are traversing the biotech valley of death — from fundamental university research into commercial development in advanced therapeutics and diagnostics. How... Read more > Press ClippingCorporateJun 27, 2022Press Clipping
Stony Brook University (SUNY)Jun22Research Centered on Single Cells May Open Doors to New Discoveries on Disease Processesby Stony Brook University (SUNY) | June 22, 2022141Stony Brook, NY | Gábor Balázsi [1] , PhD, and his research team in the Laufer Center [2] and the Department of Biomedical Engineering [3] at Stony Brook University are embarking upon a new way to res... Read more > Press ReleaseCorporateFluidFM ApplicationsJun 22, 2022Press Release
Claudia FreyMar30Cytosurge launches cell line engineering services based on proprietary FluidFM® technologyby Claudia Frey | March 30, 2022432Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for gene... Read more > Press ReleaseCorporateFluidFM ApplicationsMar 30, 2022Press Release
Claudia FreyJan18R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisseby Claudia Frey | January 18, 2022398Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) [2] at the ... Read more > Press ReleaseCorporateFluidFM ApplicationsJan 18, 2022Press Release
Claudia FreyDec22Season's Greetings & Highlights in 2021by Claudia Frey | December 22, 2021499The past year has been a year of successful transformation and growth for us, even in these difficult times. Without your support and the great work of our employees, this would not have been possible... Read more > Company BlogCompany LifeCorporateDec 22, 2021Company Blog
Claudia FreyAug04Partnership between Central Scientific Commerce and Cytosurgeby Claudia Frey | August 4, 2021909Zurich | We are delighted to announce our collaboration with CSC, a well-established and renowned Japanese organization specialized in the distribution of systems for life science research. Within thi... Read more > Press ReleaseCorporateAug 4, 2021Press Release
Claudia FreyMar24Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeksby Claudia Frey | March 24, 2021827Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation [2] , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate... Read more > Press ReleaseCorporateFluidFM ApplicationsMar 24, 2021Press Release
Claudia FreyJan27Partnership between RAMCON & Cytosurgeby Claudia Frey | January 27, 2021707Zurich | We are delighted to announce that RAMCON has been appointed as distributor in the Nordic Countries. RAMCON will distribute our FluidFM BIO Series lab solutions that enable cutting-edge experi... Read more > Press ReleaseCorporateJan 27, 2021Press Release
Claudia FreyAug26Cytosurge announces appointment of Thomas Bachmann to board of directorsby Claudia Frey | August 26, 20201333Zurich | We are pleased to announce Thomas Bachmann as a new member of our Board of Directors. Thanks to his proven and long-standing strategic management experience and his extensive network in the b... Read more > Press ReleaseCorporateAug 26, 2020Press Release
Claudia FreyJul23Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americasby Claudia Frey | July 23, 2020826Waltham, Mass. & Zurich | Olympus [1] , a leading manufacturer of high-end research microscopes, and Cytosurge [2] , a precision manufacturer of cell manipulation technologies, have entered a co-marke... Read more > Press ReleaseCorporateJul 23, 2020Press Release
Claudia FreyMay04Harvard's Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editingby Claudia Frey | May 4, 20201321Boston & Zurich | By Benjamin Boettner | Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University [1] and Cytosurge AG [2] , a company manufacturing unique high-precision ... Read more > Press ReleaseCorporateFluidFM ApplicationsMay 4, 2020Press Release
